澳大利亚警告说,与哮喘和干热药物蒙泰卢卡特相关的潜在自杀风险。 Australia warns of potential suicide risks linked to asthma and hay fever drug montelukast.

澳大利亚的药物监管者对哮喘和干热药物Montelukast发出了安全警报,并对潜在的严重情绪和行为变化,包括自杀性想法提出了警告。 Australia's drug regulator has issued a safety alert for the asthma and hay fever medication montelukast, adding warnings about potential serious mood and behavior changes, including suicidal thoughts. 根据一项将药物与焦虑和情绪紊乱等行为问题风险提高32%的研究,这些警报现在将显著地出现在患者信息传单中。 The alerts, based on a study linking the drug to a 32% higher risk of behavioral issues like anxiety and mood disorders, will now appear prominently in patient information leaflets. 建议使用者与其医生谈论风险和好处。 Users are advised to speak with their doctors about the risks and benefits.